Remedy Robotics

📍 San Francisco, United States🗓 Founded 2021👥 22 employees💰 Last funded Jan 2021
Robotics Engineering🌐 remedyrobotics.com
Website LinkedIn
Remedy Robotics exists to bring flawless, immediate, endovascular intervention (EI)—treatment for stroke, heart attack, bleeding, aneurysmal disease, pulmonary embolism and more— to every patient worldwide. Remedy is the only company in the world to have performed: - Completely robotic neurointerventional procedures in humans from start to finish. - Completely remote robotic neurointerventional procedures in humans from from start to finish. - Autonomous endovascular navigation. A few key principles underlie our work. We strongly believe that: - EI is optimizable. Tool movements should be deliberate and efficient. Procedures should be fast and effective. Complications should be avoided without exception. - All patients at elite US institutions deserve access to flawless EI without delay. But so do all patients at smaller US community hospitals. And so do all patients in Kinshasa and Port Moresby and Alice Springs and anywhere in the world. - The worlds finest technology and technologists should focus on advancing our health and wellbeing. They belong at Remedy Robotics.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Remedy Robotics?
Remedy Robotics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Remedy Robotics last raise funding?
The most recent investment in Remedy Robotics recorded on gritt.io was in January 2021.
When was Remedy Robotics founded?
Remedy Robotics was founded in 2021.
What industry is Remedy Robotics in?
Remedy Robotics operates in Robotics Engineering. Find similar Robotics Engineering investors on gritt.io.
Where is Remedy Robotics based?
Remedy Robotics is headquartered in San Francisco, United States.